Resistance to teicoplanin developing during treatment of methicillin-resistant Staphylococcus aureus infection

被引：16

作者：

Elsaghier, AAF

Aucken, HM

Hamilton-Miller, JM

Shaw, S

Kibbler, CC

机构：

[1] UCL, Royal Free & Univ Coll Med Sch, Dept Med Microbiol, London NW3 2PF, England

[2] PHLS Cent Publ Hlth Lab, Lab Hosp Infect, London NW9 5HT, England

来源：

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2002年 / 49卷 / 02期

关键词：

D O I：

10.1093/jac/49.2.423

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：423 / 424

页数：2

共 6 条

[1] Combinations of vancomycin and β-lactams are synergistic against staphylococci with reduced susceptibilities to vancomycin [J].

Climo, MW ;

Patron, RL ;

Archer, GL .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (07) :1747-1753

[2] Resistance to teicoplanin developing during treatment of methicillin-resistant Staphylococcus aureus infection [J].

Elsaghier, AAF ;

Aucken, HM ;

Hamilton-Miller, JM ;

Shaw, S ;

Kibbler, CC .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 49 (02) :423-424

[3] Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility [J].

Hiramatsu, K ;

Hanaki, H ;

Ino, T ;

Yabuta, K ;

Oguri, T ;

Tenover, FC .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 40 (01) :135-136

[4]

Howe RA, 1998, LANCET, V351, P602, DOI 10.1016/S0140-6736(05)78597-4

[5] Increased production of penicillin-binding protein 2, increased detection of other penicillin-binding proteins, and decreased coagulase activity associated with glycopeptide resistance in Staphylococcus aureus [J].

Moreira, B ;

BoyleVavra, S ;

deJonge, BLM ;

Daum, RS .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (08) :1788-1793

[6]

2000, CDR WEEKLY, V10, P99

← 1 →